ESPR- Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. (ESPR) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ESPR is classified in the Pharmaceuticals industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.47M | $4.64M | - | |
| CFO | 467.5K | $1.48M | - | |
| Other | 385.9K | $1.22M | - | |
| Other | 380.0K | $1.20M | - | |
| Dir | 177.5K | $560.1K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 7,337 | $3.67 | $26,904.78 | -1.5% | -25.8% | - | |
| Dec 17, 2025 | Looker Benjamin48 | General Counsel | Sell | 6,517 | $3.67 | $23,897.84 | -1.7% | -25.8% | - | |
| Dec 17, 2025 | Koenig Sheldon L.60 | President And CEO | Sell | 48,244 | $3.67 | $177,200.21 | -3.2% | -25.8% | - | |
| Oct 17, 2025 | Looker Benjamin48 | General Counsel | Sell | 1,248 | $2.62 | $3,275.38 | -0.3% | +13.8% | - | |
| Sep 17, 2025 | Looker Benjamin48 | General Counsel | Sell | 6,267 | $2.80 | $17,572.67 | -1.6% | +36.4% | - | |
| Sep 17, 2025 | Koenig Sheldon L.60 | President And CEO | Sell | 28,427 | $2.79 | $79,254.48 | -1.8% | +36.4% | - | |
| Sep 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 7,046 | $2.81 | $19,785.17 | -1.5% | +36.4% | - | |
| Jul 17, 2025 | Looker Benjamin48 | General Counsel | Sell | 1,304 | $1.13 | $1,469.61 | -0.3% | +103.2% | - | |
| Jul 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 11 | $1.12 | $12.27 | - | +103.2% | - | |
| Jun 17, 2025 | Looker Benjamin48 | General Counsel | Sell | 6,422 | $1.15 | $7,398.14 | -1.6% | +155.0% | +190.8% |
Page 1Next →